PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Low doses of THC can halt brain damage

Extremely low doses of marijuana's psychoactive component protect brain before and after injury, says Tel Aviv University researcher

2013-05-30
(Press-News.org) Though marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms.

Now Prof. Yosef Sarne of Tel Aviv University's Adelson Center for the Biology of Addictive Diseases at the Sackler Faculty of Medicine says that the drug has neuroprotective qualities as well. He has found that extremely low doses of THC — the psychoactive component of marijuana — protects the brain from long-term cognitive damage in the wake of injury from hypoxia (lack of oxygen), seizures, or toxic drugs. Brain damage can have consequences ranging from mild cognitive deficits to severe neurological damage.

Previous studies focused on injecting high doses of THC within a very short time frame – approximately 30 minutes – before or after injury. Prof. Sarne's current research, published in the journals Behavioural Brain Research and Experimental Brain Research, demonstrates that even extremely low doses of THC – around 1,000 to 10,000 times less than that in a conventional marijuana cigarette – administered over a wide window of 1 to 7 days before or 1 to 3 days after injury can jumpstart biochemical processes which protect brain cells and preserve cognitive function over time.

This treatment, especially in light of the long time frame for administration and the low dosage, could be applicable to many cases of brain injury and be safer over time, Prof. Sarne says.

Conditioning the brain

While performing experiments on the biology of cannabis, Prof. Sarne and his fellow researchers discovered that low doses of the drug had a big impact on cell signalling, preventing cell death and promoting growth factors. This finding led to a series of experiments designed to test the neuroprotective ability of THC in response to various brain injuries.

In the lab, the researchers injected mice with a single low dose of THC either before or after exposing them to brain trauma. A control group of mice sustained brain injury but did not receive the THC treatment. When the mice were examined 3 to 7 weeks after initial injury, recipients of the THC treatment performed better in behavioral tests measuring learning and memory. Additionally, biochemical studies showed heightened amounts of neuroprotective chemicals in the treatment group compared to the control group.

The use of THC can prevent long-term cognitive damage that results from brain injury, the researchers conclude. One explanation for this effect is pre- and post-conditioning, whereby the drug causes minute damage to the brain to build resistance and trigger protective measures in the face of much more severe injury, explains Prof. Sarne. The low dosage of THC is crucial to initiating this process without causing too much initial damage.

Preventative and long-term use

According to Prof. Sarne, there are several practical benefits to this treatment plan. Due to the long therapeutic time window, this treatment can be used not only to treat injury after the fact, but also to prevent injury that might occur in the future. For example, cardiopulmonary heart-lung machines used in open heart surgery carry the risk of interrupting the blood supply to the brain, and the drug can be delivered beforehand as a preventive measure. In addition, the low dosage makes it safe for regular use in patients at constant risk of brain injury, such as epileptics or people at a high risk of heart attack.

Prof. Sarne is now working in collaboration with Prof. Edith Hochhauser of the Rabin Medical Center to test the ability of low doses of THC to prevent damage to the heart. Preliminary results indicate that they will find the same protective phenomenon in relation to cardiac ischemia, in which the heart muscle receives insufficient blood flow.

### American Friends of Tel Aviv University supports Israel's leading, most comprehensive and most sought-after center of higher learning. Independently ranked 94th among the world's top universities for the impact of its research, TAU's innovations and discoveries are cited more often by the global scientific community than all but 10 other universities.

Internationally recognized for the scope and groundbreaking nature of its research and scholarship, Tel Aviv University consistently produces work with profound implications for the future.


ELSE PRESS RELEASES FROM THIS DATE:

Study: Pedometer program helps motivate participants to sit less, move more

2013-05-30
Indiana University researchers found that a simple program that uses pedometers to monitor how much people move throughout the day was effective at increasing physical activity, decreasing sitting time, a particular problem for office workers, and helping participants drop some pounds. "Even if somebody works out 30 minutes a day, the fact that they're sitting and not moving for long periods of time for the rest of the day is in and of itself detrimental to their health and well-being, physiologically," said Saurabh S. Thosar, an associate instructor at the IU School ...

NASA sees Hurricane Barbara quickly weaken to a depression

2013-05-30
Tropical Storm Barbara strengthened into a hurricane just before it made landfall late on May 29, and after landfall it weakened into a tropical depression. NASA satellite imagery showed that cloud tops warmed and thunderstorms became more fragmented around the storm's center after Barbara made landfall. Barbara is moving across the Isthmus of Tehuantepec today, May 30. Barbara could regenerate over the Bay of Campeche, on the Gulf of Mexico side of Mexico, and satellite imagery is watching Barbara closely. The Bay of Campeche is surrounded on three sides by the Mexican ...

Beaumont study: Nerve stimulation helps with overactive bladder

2013-05-30
Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology show participants with urinary frequency, urgency and involuntary loss of urine maintained significant improvement in their symptoms. Tibial nerve stimulation is a painless procedure that takes place in an outpatient setting. A slim needle electrode is inserted in the ankle, near the tibial nerve. It carries electric impulses from a hand-held stimulator ...

Global warming caused by CFCs, not carbon dioxide, study says

2013-05-30
WATERLOO, Ont. (Thursday, May 30, 2013) - Chlorofluorocarbons (CFCs) are to blame for global warming since the 1970s and not carbon dioxide, according to new research from the University of Waterloo published in the International Journal of Modern Physics B this week. CFCs are already known to deplete ozone, but in-depth statistical analysis now shows that CFCs are also the key driver in global climate change, rather than carbon dioxide (CO2) emissions. "Conventional thinking says that the emission of human-made non-CFC gases such as carbon dioxide has mainly contributed ...

Virginia's 'hybrid' surveillance strategy aided response to contaminated steroid outbreak

2013-05-30
Philadelphia, Pa. (May 30, 2013) – An innovative "hybrid" surveillance strategy—highlighted by close cooperation between public health officials and clinical partners—helped Virginia mount an efficient and effective response to the ongoing outbreak of fungal meningitis and other infections, according to a report in the July/August issue of Journal of Public Health Management and Practice . The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The Virginia Department of Health (VDH) "worked closely with clinical partners, combining ...

Rheumatoid arthritis patients not taking their medications as prescribed

2013-05-30
A new study conducted in an ethnically diverse and predominantly low income population found that only one-fifth of rheumatoid arthritis (RA) patients had an overall adherence rate to prescribed oral medications at 80% or greater. Findings published today in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), indicate that less than two thirds of medication regimens for non-biologic disease modifying anti-rheumatic drugs (DMARDs) were correctly followed by RA patients. According to ACR estimates, more than one million U.S. adults experience ...

Android antiviral products easily evaded, Northwestern study says

2013-05-30
Think your antivirus product is keeping your Android safe? Think again. Northwestern University researchers, working with partners from North Carolina State University, tested 10 of the most popular antiviral products for Android and found each could be easily circumnavigated by even the most simple obfuscation techniques. "The results are quite surprising," said Yan Chen, associate professor of electrical engineering and computer science at Northwestern's McCormick School of Engineering and Applied Science. "Many of these products are blind to even trivial transformation ...

Water-rock reaction may provide enough hydrogen 'food' to sustain life in ocean's crust or on Mars

2013-05-30
A chemical reaction between iron-containing minerals and water may produce enough hydrogen "food" to sustain microbial communities living in pores and cracks within the enormous volume of rock below the ocean floor and parts of the continents, according to a new study led by the University of Colorado Boulder. The findings, published in the journal Nature Geoscience, also hint at the possibility that hydrogen-dependent life could have existed where iron-rich igneous rocks on Mars were once in contact with water. Scientists have thoroughly investigated how rock-water ...

The inside story behind the approval of the gene therapy drug Glybera

2013-05-30
New Rochelle, NY, May 15, 2013—The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. In addition, an in-depth Review reveals the inside story of the European regulatory review and approval of Glybera, chock full of twists and turn, politics, and intrigue, reviews and critiques the groundbreaking drug's path to the marketplace appears in in Human Gene ...

Early brain responses to words predict developmental outcomes in children with autism

2013-05-30
The pattern of brain responses to words in 2-year-old children with autism spectrum disorder predicted the youngsters' linguistic, cognitive and adaptive skills at ages 4 and 6, according to a new study. The findings, to be published May 29 in PLOS ONE, are among the first to demonstrate that a brain marker can predict future abilities in children with autism. "We've shown that the brain's indicator of word learning in 2-year-olds already diagnosed with autism predicts their eventual skills on a broad set of cognitive and linguistic abilities and adaptive behaviors," ...

LAST 30 PRESS RELEASES:

New way to find “aged” cells marks fresh approach for research into ageing

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

New method to study catalysts could lead to better batteries

Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR

More time with loved ones for cancer patients spared radiation treatment

New methods speed diagnosis of rare genetic disease

Genetics of cardiomyopathy risk in cancer survivors differ by age of onset

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Targeting fusion protein’s role in childhood leukemia produces striking results

Clear understanding of social connections propels strivers up the social ladder

New research reveals why acute and chronic pain are so different – and what might make pain last

Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming

New research casts doubt on ancient drying of northern Africa’s climate

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

AI development: seeking consistency in logical structures

Want better sleep for your tween? Start with their screens

Cancer burden in neighborhoods with greater racial diversity and environmental burden

Alzheimer disease in breast cancer survivors

New method revolutionizes beta-blocker production process

Mechanism behind life-threatening cancer drug side-effect revealed

Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive

Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments

Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies

Exercise-induced protein revives aging muscles and bones

American College of Cardiology issues guidance on weight management drugs

Understanding the effect of bedding on thermal insulation during sleep

Cosmic signal from the very early universe will help astronomers detect the first stars

With AI, researchers find increasing immune evasion in H5N1

Study finds hidden effects of wildfires on water systems

[Press-News.org] Low doses of THC can halt brain damage
Extremely low doses of marijuana's psychoactive component protect brain before and after injury, says Tel Aviv University researcher